Postherpetic Neuralgia Pipeline Review, H1 Market 2016 Size, Share, Trends and Forecast 2016

Postherpetic Neuralgia Market Size, Share, Analysis and Causes, Symptoms, Treatment, Pipeline Review, H1 2016

Global Markets Direct's, ‘Postherpetic Neuralgia - Pipeline Review, H1 2016', provides an overview of the Postherpetic Neuralgia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Postherpetic Neuralgia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Postherpetic Neuralgia and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/postherpetic-neuralgia-pipeline-review-h1-2016

Scope

The report provides a snapshot of the global therapeutic landscape of Postherpetic Neuralgia

The report reviews pipeline therapeutics for Postherpetic Neuralgia by companies and universities/research institutes based on information derived from company and industry-specific sources

Table of Content

Table of Contents 2

List of Tables 6

Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports

List of Figures 7

Introduction 8

Global Markets Direct Report Coverage 8

Postherpetic Neuralgia Overview 9

Therapeutics...